Moderna, Inc.

Historical 13F Holders

Symbol
MRNA
CUSIP
60770K107
All holders as of
Q2 2026
Type
Equity
Class
COM
Reported Value, Excluding Options
Total Filings
Period Filings Shares, Excl. Options Value, Excl. Options
2026 Q2 873 346 M $22.7 B
2026 Q1 807 308 M $15.6 B
2025 Q4 763 305 M $9.02 B
2025 Q3 735 277 M $7.17 B
2025 Q2 759 303 M $8.35 B
2025 Q1 777 282 M $8.00 B
2024 Q4 847 277 M $11.5 B
2024 Q3 893 265 M $17.7 B
2024 Q2 1,068 269 M $32.0 B
2024 Q1 1,009 276 M $29.4 B
2023 Q4 991 269 M $26.8 B
2023 Q3 990 247 M $25.9 B
2023 Q2 1,057 249 M $30.3 B
2023 Q1 1,115 273 M $38.6 B
2022 Q4 1,178 263 M $47.6 B
2022 Q3 1,011 248 M $29.4 B
2022 Q2 1,133 245 M $35.0 B
2022 Q1 1,122 251 M $43.3 B
2021 Q4 1,213 250 M $63.5 B
2021 Q3 1,247 243 M $93.6 B
2021 Q2 999 229 M $53.9 B
2021 Q1 860 210 M $27.5 B
2020 Q4 808 201 M $21.1 B
2020 Q3 628 206 M $14.5 B
2020 Q2 544 220 M $14.1 B
2020 Q1 336 196 M $5.88 B
2019 Q4 177 177 M $3.45 B
2019 Q3 151 169 M $2.69 B
2019 Q2 161 144 M $2.10 B
2019 Q1 115 138 M $2.80 B
2018 Q4 83 134 M $2.02 B